Gennadi Saiko, PhD, is an accomplished scientist and entrepreneur with a successful track record in world-famous research institutes (Institute of General Physics, Moscow, Princess Margaret Hospital, Toronto), Fortune 500 companies (American Express), world-renowned universities (Ryerson University, Friedrich-Alexander-University of Erlangen-Nurnberg, Moscow Institute of Physics and Technology), and startups (Infinium Capital, Oxilight Inc, Swift Medical Inc). Dr. Saiko has successful experience in IP development and commercialization (founded a medical device company, Oxilight Inc, acquired by Swift Medical Inc). Dr. Saiko has extensive experience in all aspects of research: from fundamental science to applied science to industrial research to engineering. Dr. Saiko has proven track record of the development of optical modalities for healthcare. He has 23 publications in peer-reviewed journals, 7 book chapters, and more than 30 oral and poster presentations at international scientific conferences. Dr. Saiko is a member of an Executive committee of the International Society on Oxygen Transport to Tissue (ISOTT). He chaired sessions at six international conferences. Dr. Saiko is a reviewer for more than 15 peer-reviewed journals.